688687 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Beijing Kawin Technology Share-Holding Co., Ltd. research, development, production and sales of drugs in the field of viral diseases. Its products include compound glycyrrhizin capsules, vaginal effervescent tablets, omeprazole sodium for injection, liraglutide, nivolumab, and filgrastim. The company was founded on August 20, 2008 and is headquartered in Beijing, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
688687 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company